Adipocyte-derived Periostin mediates glucocorticoid-induced hepatosteatosis in mice
Objective: Long-term glucocorticoids (GCs) therapy usually causes many metabolic side effects, including fatty liver. However, the molecular mechanisms remain poorly understood. Herein, we explored the molecular basis of GCs in the development of fatty liver. Methods: C57BL/6 male mice were injected...
Saved in:
Main Authors: | Jian Wan (Author), Yi Shan (Author), Xi Song (Author), Song Chen (Author), Xinyuan Lu (Author), Jie Jin (Author), Qing Su (Author), Bin Liu (Author), Wanju Sun (Author), Bo Li (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Associations of Adipocyte-derived Versican and Macrophage-derived Biglycan with Body Adipose Tissue and Hepatosteatosis in Obese Children
by: Reyhan Deveci Sevim, et al.
Published: (2024) -
Ceramides: Nutrient Signals that Drive Hepatosteatosis
by: Scott A. Summers
Published: (2020) -
Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice
by: Sigrid Jall, et al.
Published: (2017) -
Hmgcs2-mediated ketogenesis modulates high-fat diet-induced hepatosteatosis
by: Shaza Asif, et al.
Published: (2022) -
Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome
by: Hande Erman, et al.
Published: (2020)